TODAY LETTER DATED
|
|
|
- Lenard Sherman
- 5 years ago
- Views:
Transcription
1 TODAY LETTER DATED BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE M/S. EMCURE LIMITED, PUNE M/S. GLENMARK LTD., MAHARASHTRA M/S. SUN PHARMACEUTICAL INDUSTRIES LIMITED, VADODARA TEST LICENCE AMENDMENT LETTER AMENDMENT LETTER APPROVAL LETTER NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF LETTER 1.ICMR NIRT, CHENNAI - SEC MEETING NOTICE (ANTIMICROBIAL & ANTIVIRAL) ON M/S. DR. CHANCHAL KUMAR, SENIOR RESIDENT, DEPARTMENT OF NEONATOLOGY, JIPMER, PUDUCHERRY 3.M/S. SUN PHARMA LABORATORIES LTD. (SPLL) - SEC MEETING NOTICE (NEUROLOGY & PSYCHIATRY) ON SEC MEETING NOTICE (NEUROLOGY & PSYCHIATRY) ON M/S. ALKEM - SEC MEETING NOTICE (ENDOCRINOLOGY & METABOLISM) ON M/S. GLENMARK - SEC MEETING NOTICE (ENDOCRINOLOGY & METABOLISM) ON M/S. HETERO - SEC MEETING NOTICE 7.M/S. BOEHRINGER INGELHEIM INDIA PVT LTD - SEC MEETING NOTICE 8.M/S. A. MENARINI INDIA PVT LTD - SEC MEETING NOTICE 9.M/S. G. S. PHARMABUTOR PVT LTD - SEC MEETING NOTICE 10M/S. G. S. PHARMABUTOR PVT LTD - SEC MEETING NOTICE (REPRODUCTIVE & UROLOGY) ON (2)
2 11M/S. AUROBINDO PHARMA LTD - LETTER 12M/S. TORRENT LTD QUERY LETTER 13HELIXOR HEILMITTEL PVT LTD - LETTER 14M/S. PHARMAZZ INDIA PVT LTD QUERY LETTER 15M/S. MSN LAB PVT LTD - QUERY LETTER 16M/S. SANOFI-SYNTHELABO (I) PVT LTD - LETTER 17M/S. BAYER PVT LTD - QUERY LETTER SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF LETTER 1. M/S ICMR SEC INVITATION LETTER FOR UPCOMING SEC ANTIMICROBIAL & ANTIVIRAL ON M/S ZIM LABORATORIES SEC INVITATION LETTER FOR 3. M/S ZIM LABORATORIES SEC INVITATION LETTER FOR 4. M/S INTAS SEC INVITATION LETTER FOR 5. M/S AJANTA PHARMA - - SEC INVITATION LETTER FOR UPCOMING SEC ANALGESIC & RHEUMATOLOGY ON M/S THEMIS MEDICARE SEC INVITATION LETTER FOR UPCOMING SEC ANALGESIC & RHEUMATOLOGY ON M/S INTAS SEC INVITATION LETTER FOR UPCOMING SEC ENDOCRINOLOGY & METABOLISM ON M/S ASTRAZENCA SEC INVITATION LETTER FOR 9. M/S INTAS SEC INVITATION LETTER FOR 10. M/S BMS SEC INVITATION LETTER FOR
3 11. M/S VIRCHOW SEC INVITATION LETTER FOR 12. M/S UNIQUE SEC INVITATION LETTER FOR UPCOMING SEC PULMONARY ON M/S GURMAIL BROTHER SEC INVITATION LETTER FOR UPCOMING SEC REPRODUCTIVE & UROLOGY ON M/S SYNOKEM SEC INVITATION LETTER FOR UPCOMING SEC REPRODUCTIVE & UROLOGY ON M/S SYNOKEM DEFICIENCY LETTER 16. M/S RUSAN PHARMA DEFICIENCY LETTER (2) 17. M/S CADILA HEALTHCARE DEFICIENCY LETTER 18. M/S LAURUS LABS DEFICIENCY LETTER 19. M/S INTAS DEFICIENCY LETTER MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. CENTRAL GLASS & CERAMIC RESEARCH INSTITUTE, (CSIR) 5992 LETTER 2. M/S. MERIL LIFE SCIENCES PVT. LTD., 214 LETTER 3. M/S. MERIL LIFE SCIENCES PVT. LTD., LETTER 4. M/S. RECKITT BENCKISER (INDIA) PVT. LTD., LETTER 5. M/S. STERIMED SURGICALS (I) PVT. LTD., LETTER 6. M/S. REGENCY LIFE SCIENCES INDIA PVT. LTD., LETTER
4 7. M/S. NIRAMAI HEALTH ANALYTIX PVT. LTD., LETTER DIAGNOSTIC DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ADT, INDIA PVT. LTD., LETTER 2. M/S. ANNWESHAN SCI TECH PVT. LTD., LETTER 3. M/S. SYNERGY MEDICAL SYSTEMS LLP., LETTER BIOLOGICAL DIVISION S. NO. NAME OF FIRM REFERENCE NO. TYPE OF LETTER 1 M/S NOVO NORDISK INDIA 9215 ACKNOWLEDGE LETTER 2 M/S BAYER ACKNOWLEDGE LETTER 3 M/S ROCHE PRODUCTS INDIA 7844 ACKNOWLEDGE LETTER 4 M/S HETERO BIOPHARMA LTD ACKNOWLEDGE LETTER 5 M/S SANDOZ PVT LTD ACKNOWLEDGE LETTER 6 M/S MSD CDL & CLARIFICATION LETTER 7 M/S PANACEA BIOTECH LTD CDL LETTER 8 M/S SERUM INSTITUTE OF INDIA 9 M/S JOHNSON & JOHNSON 10 M/S BHARAT BIOTECH INTERNATIONAL LTD 11 M/S MERCK SPECIALTIES PVT, LTD CLARIFICATION LETTER CLARIFICATION LETTER CLARIFICATION LETTER AMENDMENT & CLARIFICATION LETTER
5 FDC DIVISION S.NO. NAME OF COMPANY DIARY NO. DOCUMENT 1. M/S. ERIS LIFE SCIENCES 9202/NIL LETTER/SEC LETTER 2. M/S. SIGMA-TAU INDIA NIL SEC MEETING
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 13.06.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. Type of letter 1. M/s. Alembic Pharmaceuticals Ltd., Vadodara- 390003 2. M/s. Alkem Laboratories Ltd., Taloja-410208,
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 20.12.2017 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. ELI LILLY 29559 PA APPROVAL LETTER 2 M/S. NOVARTIS 26200 SITE APPROVAL LETTER MEDICAL DEVICE DIVISION
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
Desire to Work Together
IPA Meeting with the FDA Desire to Work Together by DGShah Secretary General Indian Pharmaceutical Alliance Washington DC 13 April 2015 1 Desire to Work Together Outline of Presentation About IPA McKinsey
Method of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
Participating Indian Companies 1 5M Biotech India 2 Aarti Drugs Ltd. 3 Aarti Industries Limited 4 Aastrid International Pvt. Ltd 5 Aastrid Life
S.No. Participating Indian Companies 1 5M Biotech India 2 Aarti Drugs Ltd. 3 Aarti Industries Limited 4 Aastrid International Pvt. Ltd 5 Aastrid Life Sciences Pvt. Ltd. 6 Accent Microcell Pvt. Ltd. 7 Accutest
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF MARCH-2016 DATE OF HEARING 01.03.2016 Application / 1. 920120/30 Rect. AMD-260953 M/s. Kaira District Cooperative Milk Producers
Corporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
LIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
The Role of Patients in Transitions of Care
Play an Active Role It is crucial that you play an active role in your own healthcare. During treatment, you may see more than one provider. You also may visit more than one care setting. In each case,
2017 IPCC Attendee List
2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.
Day Hrs Inaugural Session
Day 1 14 th National Pharmaceutical Conclave 2017 Maximizing the Pharmaceutical Opportunity for India Vision and Roadmap- 2025 20 21 December 2017: Hotel Le Meridien, New Delhi Draft Programme 0930-1045
State of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
Half-Day Seminar on. Life Sciences Patent Protection in US and India
Half-Day Seminar on Life Sciences Patent Protection in US and India LEARN FOR WHOM Learn about the scope and strategies of patent protection in the US (world s largest market for biotech products) and
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
ASMI Committee of Management
Lindsay Forrest ASMI President ASMI Vice President/Secretary 2008-2010; Chair of ASMI Membership Services Subcommittee 2008-2010 Regional Director, Reckitt Benckiser Australia & New Zealand. Lindsay currently
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
MARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013
MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters
Early Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
Aqua Pharmaceuticals, LLC
Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
The 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
Intellectual Property for Industry and Academia Professionals: Training the Trainers
Intellectual Property for Industry and Academia Professionals: Training the Trainers!! Recognize and Protect Scientific Discovery with the Rights it Deserves!! 1.5 Day Professional Development Program
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
A Innovative International Limited
+91-8048737779 A Innovative International Limited https://www.indiamart.com/waterjet/ A innovative international ltd. Is the pioneer Indian manufacturing company specialized and engaged in production of
Innovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF NOVEMBER-2013 DATE OF HEARING 11.11.2013 R. T. M. 1. 751881/05 Opp. AMD-718038 M/s. Cipla Limited, / M/s. Jasani & Company, Rajkot
Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
SUMMARY OF PROFESSIONAL EXPERIENCE (Nadeem Hussain Alamgir)
SUMMARY OF PROFESSIONAL EXPERIENCE (Nadeem Hussain Alamgir) I have worked for >30 years in Healthcare industry where I am respected because of my professional capabilities in sales/marketing and in understanding
Notice for Placement
Notice for Placement 12 Feb 2016. Company Name:- Akar Ltd Position:- Export Executive and Excise Officer (1 each) Company Website:- www.akar.co.in Work Location:- Silvassa About Company: refer attachment
People. Move PHARMA COMPANIES. on the. Abbott Nutrition International. AstraZeneca. Axcan Pharma. Berlex. Bristol-Myers Squibb
People on the Move PHARMA COMPANIES Gary Schmid Abbott Nutrition International Crawford Wright AstraZeneca Abbott Nutrition International Gary Schmid, formerly Director of Marketing, Primary Care Division,
IndiaNivesh Securities Private Limited STOCK HOLDING DISCLOSURE LIST AS ON MAY 30, 2015
IndiaNivesh Securities Private Limited 601 & 602, Sukh Sagar, N. S. Patkar Marg, Girgaum Chowpatty, Mumbai 400 007. Tel: (022) 66188800 / Fax: (022) 66188899 e-mail: research@indianivesh.in Website: www.indianivesh.in
D. P. AHUJA & CO. PATENT & TRADEMARK ATTORNEYS
S. D. AHUJA S. CHAKRABORTY S. R. GUPTA K. M. RAO R. SIRCAR A. K. CHATTERJEE M. ISLAM Dr. I. S. BHATTACHARYA S. K. GUE Dr. S. K. CHAUDHURI B. DAS M. MAHARAJ A. SINGH C. MUKHERJEE M. GAUR S. MANI D. K. CHAUDHRY
Postgraduate Diploma In Patinformatics (Patent Informatics)
URDIP Postgraduate Diploma In Patinformatics (Patent Informatics) Offered by CSIR Unit for Research and Development of Information Products (URDIP) Under the Aegis of Admission Brochure (2017 2018) About
1 Day Seminar on Current Themes in Pharma Patenting - Organized by IPFACE, Venture Center & IP Group, NCL Innovations -
1 Day Seminar on Current Themes in Pharma Patenting - Organized by IPFACE, Venture Center & IP Group, NCL Innovations - LEARN ORGANIZED BY SUPPORTED BY FOR WHOM WHEN IPFACE LEAD WHERE CONTACT Overview
Generics Series: Authorized Generics Analysis Stemming the Generics Tide
Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players
PLACEMENT BROCHURE Tapping the.. Untapped reservoir of talent
PLACEMENT BROCHURE ------------------ 2016-2017 Tapping the.. Untapped reservoir of talent MESSAGE FROM THE EXECUTIVE DIRECTOR Dear Recruiter, Greetings from TIFAC! The Women Scientists Scheme-C (WOS-C),
Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,
Biotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
Using Academic Licensing Agreements to Promote Global Social Responsibility
Using Academic Licensing Agreements to Promote Global Social Responsibility Equitable Licensing of Medical Research Results Charité - Universitätsmedizin Berlin April 26, 2009 Dr. Ashley J. Stevens Executive
TUESDAY, 16 FEBRUARY AT THE COURTYARD MARRIOTT, MUMBAI Opp. Big Cinema (Old Sangam Cinema) Andheri Kurla Road, Andheri East HOSTED BY MEDICINMAN
FFE 2016 TUESDAY, 16 FEBRUARY AT THE COURTYARD MARRIOTT, MUMBAI Opp. Big Cinema (Old Sangam Cinema) Andheri Kurla Road, Andheri East KEYNOTE SPEAKER Darshan Patel - Partner, PwC CEO ROUNDTABLE FIELD FORCE
Quarterly Issue Volume 8.3. Dealtracker. Providing M&A and PE market insights. Grant Thornton India LLP. All rights reserved.
Quarterly Issue. Providing M&A and PE market insights Quarter, : Deal Snapshot Quarter Deal Summary Q Deal Summary Domestic 9% Destination Of M&A Deals Q Crossborder % Inbound % (US$ bn) Year Inbound..7.
Why Value Intellectual Property?
Why Value Intellectual Property? The importance of intellectual property is reflected in everything around us and challenges old established ideas and concepts. In this millennium, the international role
PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
INDIAN SOCIETY FOR CLINICAL RESEARCH
INDIAN SOCIETY FOR CLINICAL RESEARCH 12 th Annual Conference Clinical Research Advancing the Frontiers of Health February 15-16, 2019, New Delhi Pre-Conference Workshops February 14, 2019 Workshop - Career
SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting Tokyo, Japan March 16, 2010 Astellas Pharma Inc. (TSE: 4503) today notified
on the Anne Berberi, formerly Product Manager, Diabetes, at Bristol-Myers Squibb, has been appointed Senior Brand Manager, HCV, at AbbVie.
PEOPLE Copyright on the MOVE Not for Sale or Commercial Distribution Unauthorised use prohibited. Authorised users can download, display, view and print a single copy for personal use PHARMA COMPANIES
PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)
PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS) The Post-Graduates will acquire adequate scientific information regarding basic principles of Pharmaceutics including Cosmetology, Specialized drug
International Journal of Pharma and Bio Sciences PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY ABSTRACT
Research Article Analytical Chemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY SARAVANA KUMAR.V
PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
MONTHLY. Volume 2 Issue
MONTHLY Volume 2 Issue 10 01.2013 INDUSTRY INDUSTRY FOCUS FOCUS - INDIAN INDIAN PHARMACEUTICAL PHARMACEUTICAL SECTOR SECTOR Creating value, partners in growth LSI Financial Services is a leading provider
VINATI ORGANICS LIMITED
VINATI ORGANICS LIMITED Head Quarters: Shiv Ashish, II nd Floor, Andheri Kurla Road, Saki Naka, Andheri (E). Mumbai 400 072, India. www.vinatiorganics.com Vinati Organics Limited A company established
Optics and Spectroscopy for Medical Diagnostics Learn Make Explore! Organized by Venture Center
Learn Organized by For whom When Where Contact Tinkering lab: Tinkering Lab Technical Workshops Series 2017 Two Days Hands on Workshop on Optics and Spectroscopy for Medical Diagnostics Learn Make Explore!
International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs
International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs Do you want to strengthen your business plan for your company?, or refresh your
APPLIED ELECTRONIC CIRCUITS
SRM UNIVERSITY DEPARTMENT OF BIOMEDICAL ENGINEERING ODD Semester-2014-2015 BM1005 APPLIED ELECTRONIC CIRCUITS Course Code: BM1005 Course Title: APPLIED ELECTRONIC CIRCUITS Sem: III SEM B. Tech Second Year
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions FRIDAY, 4 MAY 8:30 AM 3 PM New York Genome Center 101 Avenue of the Americas New York, NY 10013 HBAnet.org Event
INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH
INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH Sharing Information, Knowledge and Materials Dr. Ashley J. Stevens Executive Director, Technology Transfer Senior Research Associate
Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
PRESS RELEASE Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 Paris, France May 23, 2016 - Sanofi Chief Executive Officer Olivier Brandicourt, MD, announced today
2018 IPCC Attendee List
2018 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2018 Title Head of Intellectual Property Vice President IP Asst. Program Officer Health Supervisor Public Health Asst. Health Youth
The 2010 EU industrial R&D investment SCOREBOARD
1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D
Launch of new transatlantic specialty pharma company
For immediate release Thursday 1 March 2007 EUSA Pharma Inc ( EUSA Pharma or the Company ) Launch of new transatlantic specialty pharma company EUSA Pharma raises $175m for both the acquisition of OPi
Chief Trademark Counsel Teva Pharmaceuticals, Inc.
David S. Weinstock, Esq. Program Moderator David Weinstock has served as in-house and outside counsel advising prescription and OTC drug, biotech, medical device and cosmetic companies, including Boehringer
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JANUARY-2016 DATE OF HEARING 04.01.2016 / 1. 918073/16 Opp. AMD-195756 M/s. Academy of Computer Technology, / M/s. Y. J. Trivedi
Life Sciences Outlook
New Jersey 2018 JLL Research Report Life Sciences Outlook Breakthrough discoveries at a breathtaking pace 2 New Jersey The pharmaceutical/life sciences industry has historically been one of New Jersey
Life Sciences Outlook. Westchester County 2016
Life Sciences Outlook Westchester County 2016 Westchester County Just a short distance from Manhattan, Westchester County is an ideal location to many firms looking to attract and retain talent. The access
L équipe de direction de Sandoz Canada est diversifiée et détient une vaste expérience dans l industrie pharmaceutique.
Published on Sandoz Canada (https://www.sandoz.ca) Home > Printer-friendly PDF > Dirigeants au Canada Canada Leadership L équipe de direction de Sandoz Canada est diversifiée et détient une vaste expérience
The Shape of Things to Come: Massachusetts June 18, 2010 Newton Marriott Hotel
The Shape of Things to Come: Massachusetts 2020 June 18, 2010 Newton Marriott Hotel Mark Nemec, Ph.D Managing Director, Technology Industry Client Group Forrester Research Some Thoughts on The Reset Economy
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JULY-2014 DATE OF HEARING 07.07.2014 R. T. M. 1. 722643/05 Opp. AMD-117386 Water Bushnell Private Ltd., / Mr. Manoj G. Menda, Cadila
Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP
Management Oversight and Control: How to Ensure Compliance and Limit Liability
Management Oversight and Control: How to Ensure Compliance and Limit Liability Jennifer L. Bragg, Partner, Skadden, Arps, Slate, Meagher & Flom LLP and Member, FDLI Board of Directors Ricki A. Chase, Director,
Opportunities for the pharma supply & support network in Emerging Markets
Opportunities for the pharma supply & support network in Emerging Markets Parioforma Ltd 55 Princes Gate Exhibition Road South Kensington London SW7 2PN United Kingdom www.parioforma.com Emerging markets
NEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH
NEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH TABLE OF CONTENTS Cushman & Wakefield 2 3 KEY TAKEAWAYS 4 ECONOMIC IMPACT 5 R&D / FLEX MARKET 6 CLASS A OFFICE MARKET 7 LIFE SCIENCES
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems May 18 th, 2017 Location: Gasometer, EUREF-Campus 17, 10829 Berlin Conference Agenda (as of
INDIAN INSTITUTE OF MANAGEMENT CALCUTTA WORKING PAPER SERIES. WPS No. 653/ April Trends in Pharmaceutical Patenting in India
INDIAN INSTITUTE OF MANAGEMENT CALCUTTA WORKING PAPER SERIES WPS No. 653/ April 2010 Trends in Pharmaceutical Patenting in India by Anant Prakash Srivastava Examiner of Patents & Designs, Patent Office,
Gerresheimer CAPITAL MARKETS DAY 2010
Gerresheimer CAPITAL MARKETS DAY 2010 Gerresheimer Today September 1, 2010 Uwe Röhrhoff, CEO Gerresheimer who we are and what we do Gerresheimer is an important partner of the pharmaceutical and healthcare
Facets of Technology Transfer: A Perspective of Pharmaceutical Industry
Journal of Intellectual Property Rights Vol 13, January 2008, pp 28-34 Facets of Technology Transfer: A Perspective of Pharmaceutical Industry Manthan D Janodia, D Sreedhar, Virendra S Ligade, Ajay Pise,
IP for Development Indian Approach
ARAB REPUBLIC OF EGYPT MINISTRY OF FOREIGN AFFAIRS ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY WORLD INTELLECTUAL PROPERTY ORGANISATION Second WIPO Inter-Regional Meeting on South-South Cooperation on
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF AUGUST-2017 DATE OF HEARING 01.08.2017 1. 1039854/05 Opp. AMD-233690 Limited, / Mr. M/s. Treffer Pharmaceuticals, Navsari / M/s.
Jagadguru Sri Shivarathreeshwara University (Deemed University) Accredited A Grade by NAAC ONE DAY SEMINAR
Jagadguru Sri Shivarathreeshwara University (Deemed University) Accredited A Grade by NAAC ONE DAY SEMINAR ON Challenges to Patentability in Pharma Sector Date: 16 th September 2017 10:00 AM to 4:30 PM
Conferences. March 17-18, th National Conference And Technology Exhibition on
Indian Medical Device Industry Conferences www.imdiconferences.com EVENTREPORT2017 March 17-18,2017 14th National Conference And Technology Exhibition on In Conjunction With: Indian Medical Devices & Plastics
Digital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
Newsletter on Indian Healthcare Industry
24 th Jan 5 th Feb 11 PharmaHealth TRACK Newsletter on Indian Healthcare Industry Top Story Content Results Declared: Sector sees positive results except few dips Pharma and healthcare sector has so far
Life Sciences Outlook. New York City 2016
Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations
Sino American Pharmaceutical Professionals Association 美中醫藥開發協會 Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations August 3-4, 2012 New Jersey, USA PRELIMINARY PROGRAM
G:\# 2010\Presse\Unternehmensprofile\Englisch\BINDER_Company_Profile_KBA_2010.doc
BINDER GmbH Quality is one of the most important factors for customers when establishing confidence in a company. This is why product safety has top priority in manufacturing, and in the Life Sciences
Purvi B. Maniar Member of the Firm
Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the
India's potential as a global biopharma
POST EVENT M A R K E T Leaders speak at US-India BioPharma & Healthcare Summit 2011 CXOs from the global biopharma shared the dais with their Indian counterparts in a frank sharing of concerns and suggested